glp 1 data Rx Trends: Real-World on GLP-1s for Weight Loss GLP-1 Receptor Agonist Market Size

Description

ncbi.nlm.nih.gov/pmc/articles/PMC5397288/ #2

Tirzepatide, the active ingredient in Eli Lilly's Zepbound and diabetes injection Mounjaro, likely won't be eligible for those negotiations until the end of the decade.

Data presented are for the efficacy estimand unless otherwise noted CVD cardiovascular disease, HbA1c glycated hemoglobin, MACE major adverse cardiac events, MMO morbidity mortality obesity, T2D type 2 diabetes a MACE-5 comprised all-cause death, nonfatal myocardial infarction, nonfatal stroke, unstable angina requiring hospitalization or revascularization, and coronary revascularization Table 3

India is emerging in the GLP-1 targeted peptide weight loss drugs market due to its large and growing population affected by obesity and diabetes, creating a substantial patient base